Changes to Medicaid funding, eligibility and enrollment could impact hospital finances. This interactive map shows the number of hospitals in each congressional district. There is at least one hospital in each of the 435 congressional districts.
Este verano, durante una cena con su mejor amiga, Jacki Barden habló de un tema incómodo: la posibilidad de morir sola. “No tengo hijos, ni esposo, ni hermanos”, recordó haber dicho Barden. “¿Quién va a sostener mi mano cuando muera?”. Barden, de 75 años, nunca tuvo hijos. Vive sola en el oeste de Massachusetts desde…
Johnson & Johnson’s Imaavy is now FDA-approved for treating generalized myasthenia gravis, introducing competition to Argenx and UCB drugs that treat this rare neuromuscular disorder. J&J is also developing its new drug for other diseases and projects it could reach $5 billion in peak sales across multiple rare and prevalent conditions. The post FDA Nod…
Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. The post Prioritize Provider Data for Seamless M&A Success appeared first on MedCity News.
KFF Health News senior correspondent Renuka Rayasam discussed the KFF Health News series “Priced Out,” which focuses on the health insurance crisis, on An Arm and a Leg on March 19. Click here to hear Rayasam on An Arm and a Leg (starts at 21:03). Read Rayasam’s “When Health Insurance Costs More Than the Mortgage.”…
Implementing a thorough federal privacy law and broadening HIPAA protections to include new mHealth technologies are crucial steps in enhancing personal data security. Equally important, companies and developers should adhere to strict ethical standards and robust security protocols during app development to protect users’ sensitive information. The post Mental Health Data Sells, But Who’s Buying?…
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to…
Investors showed appetite for Metsera’s IPO, as shares of the clinical-stage metabolic medicines biotech popped 47% in their Nasdaq debut. Maze Therapeutics and Beta Bionics also priced IPOs; the three companies raised $636 million combined. The post Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s appeared first on MedCity…
Kura Oncology’s Komzifti is approved for treating advanced cases of acute myeloid leukemia with an NPM1 mutation. A Syndax Pharmaceuticals drug is already approved in this indication, but Kura says its drug has advantages in safety and patient convenience. The post FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma appeared first…
Amid the challenges of adulthood, one rite of passage is unique to the United States: the need to find your own health insurance by the time you turn 26. That is the age at which the Affordable Care Act declares that young adults generally must get off their family’s plan and figure out their coverage…